US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

24.70

+0.91003.83%

Post-market: 24.700.00000.00%18:25 EST

Volume:2.68M

Turnover:65.85M

Market Cap:2.38B

PE:-4.16

High:24.87

Open:24.25

Low:23.89

Close:23.79

52wk High:46.27

52wk Low:18.41

Shares:96.48M

Float Shares:92.79M

Volume Ratio:1.00

T/O Rate:2.89%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.9427

EPS(LYR):-6.2867

ROE:-313.43%

ROA:-24.92%

PB:260.18

PE(LYR):-3.93

Loading ...

Overview Company News Filings

Ultragenyx Pharmaceutical Inc. to Host Conference Call for Financial Results and Corporate Update

Ultragenyx Faces Investor Lawsuit Over Alleged Misleading Statements on Drug Trial Results

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Pfizer (PFE)

Ultragenyx Says Gene Therapy Shows Lasting Benefits, Slows Brain Decline In Fatal Childhood Disorder

Benzinga_recent_news

Ultragenyx CFO Howard Horn Reports Disposal of Common Shares

BUZZ-U.S. STOCKS ON THE MOVE-JetBlue, VSE, Walt Disney

Ultragenyx Says Long-Term Data Show UX111 Provides Clinical Benefits in Sanfilippo Syndrome

MT Newswires Live

Ultragenyx Pharma Price Target Maintained With a $60.00/Share by HC Wainwright & Co.

BRIEF-Ultragenyx: Long-Term UX111 Data Shows Sustained CSF-HS Reductions, Multi-Domain Gains In Children With Sanfilippo Syndrome (Mps Iiia)

Ultragenyx Announces Positive Longer-Term Data Demonstrating Treatment With Ux111 Gene Therapy Results in Sustained, Significant Reductions in Csf-Hs and Continued Meaningful Improvements in Clinical Function Across Multiple Developmental Domains in Children With Sanfilippo Syndrome (Mps Iiia)

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc - Results Show Substantial Biomarker Improvements and Functional Benefits

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc - Ux111 Well Tolerated Across All Doses

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc - Bla Resubmitted to FDA, Six-Month Review Expected

THOMSON REUTERS

Ultragenyx Resubmits BLA for UX111 Gene Therapy to FDA with PDUFA Date Expected in Q3

Ultragenyx BLA Resubmission Puts UX111 And RARE Valuation In Focus

Simply Wall St.

Ultragenyx Resubmits FDA Application for Potential Therapy for Rare Neurodegeneration Disease

MT Newswires Live

Ultragenyx resubmits BLA for UX111 gene therapy with FDA

FDA Grants Priority Review to Ultragenyx BLA for UX111 Gene Therapy for Sanfilippo Syndrome Type A

Ultragenyx Pharmaceutical Inc: Expects up to Six-Month Review Period per FDA Guidelines

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc - Bla Includes Responses to Cmc Observations From July 2025 Crl

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RARE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RARE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","market":"US","secType":"STK","nameCN":"Ultragenyx Pharmaceutical","latestPrice":24.7,"timestamp":1770411600000,"preClose":23.79,"halted":0,"volume":2679737,"hourTrading":{"tag":"盘后","latestPrice":24.7,"preClose":24.7,"latestTime":"18:25 EST","volume":28973,"amount":715633.69,"timestamp":1770420309615,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03825136612021859,"floatShares":92794919,"shares":96477569,"eps":-5.942723,"marketStatus":"Market Closed","change":0.91,"latestTime":"02-06 16:00:00 EST","open":24.25,"high":24.87,"low":23.89,"amount":65852197.364599004,"amplitude":0.041194,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.942723,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":23.79,"preHourTrading":{"tag":"盘前","latestPrice":24.5,"preClose":23.79,"latestTime":"08:00 EST","volume":90,"amount":2205,"timestamp":1770382804114,"change":0.71,"changeRate":0.029844,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":24.7,"preClose":24.7,"latestTime":"18:25 EST","volume":28973,"amount":715633.69,"timestamp":1770420309615,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9999797745697495,"impliedVol":0.5092,"impliedVolPercentile":0.3546},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","floatShares":92794919,"roa":"-24.92%","roe":"-313.43%","lyrEps":-6.286667,"volumeRatio":0.9999797745697495,"shares":96477569,"dividePrice":0,"high":24.87,"amplitude":0.041194,"preClose":23.79,"low":23.89,"week52Low":18.41,"pbRate":"260.18","psRate":"3.78","week52High":46.27,"institutionHeld":0,"latestPrice":24.7,"eps":-5.942723,"divideRate":0,"volume":2679737,"delay":0,"ttmEps":-5.942723,"open":24.25,"prevYearClose":23,"prevWeekClose":24.07,"prevMonthClose":24.07,"prevQuarterClose":23,"fiveDayClose":24.07,"twentyDayClose":23.21,"sixtyDayClose":31.94,"earningDate":1770825600000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RARE\",params:#limit:5,,,undefined,":[{"date":"2026-02-12","symbol":"RARE","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":-1.22,"defaultRemindTime":1770930000000,"name":null,"time":"Post Market","dateTimestamp":1770872400000,"actualEps":null},{"market":"US","date":"2026-01-12","symbol":"RARE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-11-04","symbol":"RARE","fiscalQuarterEnding":"2025/09","expectedEps":-1.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-1.81},{"market":"US","date":"2025-08-05","symbol":"RARE","fiscalQuarterEnding":"2025/06","expectedEps":-1.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-1.17},{"market":"US","date":"2025-05-06","symbol":"RARE","fiscalQuarterEnding":"2025/03","expectedEps":-1.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-1.57}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RARE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RARE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.619,"hold":0.0476,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.619,"analysts":21,"updateTime":1748408400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RARE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RARE","date":"2026-02-06","current":-4.156344,"percent":0.914824,"low":-57.721347,"twenty":-13.236481,"median":-6.373339,"eighty":-4.730852,"high":-3.237111,"avg":-10.34036,"sd":9.949714,"marketCap":2291084887},"quantilePoints":[{"date":"2021-02-12","current":-53.920829,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":10059793403},{"date":"2021-02-19","current":-53.160067,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9917861006},{"date":"2021-02-26","current":-50.791655,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9475995995},{"date":"2021-03-05","current":-42.523747,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7933485414},{"date":"2021-03-12","current":-45.556031,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":8499206525},{"date":"2021-03-19","current":-44.759384,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":8350579204},{"date":"2021-03-26","current":-38.985484,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":7273365868},{"date":"2021-04-01","current":-40.621841,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":7578654420},{"date":"2021-04-09","current":-37.133817,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6927907769},{"date":"2021-04-16","current":-39.014192,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7278721807},{"date":"2021-04-23","current":-39.42687,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7355713438},{"date":"2021-04-30","current":-40.376431,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7532869144},{"date":"2021-05-07","current":-37.945412,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7728797410},{"date":"2021-05-14","current":-36.736115,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7482485435},{"date":"2021-05-21","current":-35.563263,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7243596560},{"date":"2021-05-28","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-04","current":-30.543853,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6221233155},{"date":"2021-06-11","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-18","current":-31.448341,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6405461016},{"date":"2021-06-25","current":-31.087209,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":6331904837},{"date":"2021-07-02","current":-31.213108,"twenty":-30.257731,"median":-15.161272,"eighty":-8.834973,"marketCap":6357548275},{"date":"2021-07-09","current":-30.262236,"twenty":-30.265324,"median":-15.161272,"eighty":-8.834973,"marketCap":6163872832},{"date":"2021-07-16","current":-28.271038,"twenty":-30.233301,"median":-15.161272,"eighty":-8.834973,"marketCap":5758301606},{"date":"2021-07-23","current":-27.406308,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":5582171673},{"date":"2021-07-30","current":-26.44881,"twenty":-29.79768,"median":-15.161272,"eighty":-8.834973,"marketCap":5387146575},{"date":"2021-08-06","current":-17.083279,"twenty":-29.687102,"median":-15.161272,"eighty":-8.834973,"marketCap":6003491310},{"date":"2021-08-13","current":-17.901732,"twenty":-29.496644,"median":-15.161272,"eighty":-8.834973,"marketCap":6291116204},{"date":"2021-08-20","current":-15.473397,"twenty":-29.315394,"median":-15.15171,"eighty":-8.834973,"marketCap":5437738569},{"date":"2021-08-27","current":-18.1353,"twenty":-29.179331,"median":-15.15171,"eighty":-8.834973,"marketCap":6373197837},{"date":"2021-09-03","current":-19.766415,"twenty":-28.984947,"median":-15.15171,"eighty":-8.834973,"marketCap":6946412544},{"date":"2021-09-10","current":-19.629363,"twenty":-28.634625,"median":-15.15171,"eighty":-8.834973,"marketCap":6898248941},{"date":"2021-09-17","current":-18.969196,"twenty":-28.497709,"median":-15.15171,"eighty":-8.834973,"marketCap":6666249616},{"date":"2021-09-24","current":-18.359217,"twenty":-28.236842,"median":-15.15171,"eighty":-8.834973,"marketCap":6451887666},{"date":"2021-10-01","current":-16.948157,"twenty":-28.151413,"median":-15.15171,"eighty":-8.834973,"marketCap":5956006068},{"date":"2021-10-08","current":-15.759084,"twenty":-28.053185,"median":-15.15171,"eighty":-8.834973,"marketCap":5538135938},{"date":"2021-10-15","current":-15.442512,"twenty":-27.812745,"median":-15.15171,"eighty":-8.834973,"marketCap":5426884800},{"date":"2021-10-22","current":-15.098916,"twenty":-27.55852,"median":-15.082382,"eighty":-8.834973,"marketCap":5306136613},{"date":"2021-10-29","current":-16.199195,"twenty":-27.366816,"median":-15.082382,"eighty":-8.834973,"marketCap":5692802155},{"date":"2021-11-05","current":-15.975791,"twenty":-27.236045,"median":-15.082382,"eighty":-8.834973,"marketCap":5680639831},{"date":"2021-11-12","current":-15.43713,"twenty":-27.171258,"median":-15.082382,"eighty":-8.834973,"marketCap":5489103979},{"date":"2021-11-19","current":-15.205181,"twenty":-26.927437,"median":-15.06031,"eighty":-8.834973,"marketCap":5406627687},{"date":"2021-11-26","current":-14.662686,"twenty":-26.731524,"median":-14.936554,"eighty":-8.834973,"marketCap":5213728590},{"date":"2021-12-03","current":-14.570673,"twenty":-26.554402,"median":-14.855697,"eighty":-8.834973,"marketCap":5181010722},{"date":"2021-12-10","current":-14.932975,"twenty":-26.360162,"median":-14.855697,"eighty":-8.834973,"marketCap":5309837327},{"date":"2021-12-17","current":-16.265249,"twenty":-26.205264,"median":-14.855697,"eighty":-8.834973,"marketCap":5783564791},{"date":"2021-12-23","current":-16.244163,"twenty":-25.908959,"median":-14.855697,"eighty":-8.834973,"marketCap":5776066946},{"date":"2021-12-31","current":-16.119562,"twenty":-25.241061,"median":-14.855697,"eighty":-8.834973,"marketCap":5731761500},{"date":"2022-01-07","current":-14.145112,"twenty":-24.735967,"median":-14.855038,"eighty":-8.83563,"marketCap":5029690582},{"date":"2022-01-14","current":-13.811564,"twenty":-24.180303,"median":-14.806289,"eighty":-8.83563,"marketCap":4911088311},{"date":"2022-01-21","current":-12.876097,"twenty":-23.989848,"median":-14.747324,"eighty":-8.83563,"marketCap":4578456653},{"date":"2022-01-28","current":-12.651814,"twenty":-23.661155,"median":-14.661474,"eighty":-8.83563,"marketCap":4498706850},{"date":"2022-02-04","current":-13.154053,"twenty":-23.48091,"median":-14.600648,"eighty":-8.83563,"marketCap":4677291879},{"date":"2022-02-11","current":-10.94589,"twenty":-23.205637,"median":-14.505395,"eighty":-8.83563,"marketCap":4969707824},{"date":"2022-02-18","current":-10.194721,"twenty":-23.125145,"median":-14.35823,"eighty":-8.83563,"marketCap":4628658273},{"date":"2022-02-25","current":-10.307809,"twenty":-22.914219,"median":-14.283419,"eighty":-8.83563,"marketCap":4680003006},{"date":"2022-03-04","current":-9.594133,"twenty":-22.459434,"median":-14.16111,"eighty":-8.83563,"marketCap":4355976111},{"date":"2022-03-11","current":-9.996053,"twenty":-21.586553,"median":-14.118393,"eighty":-8.83563,"marketCap":4538458067},{"date":"2022-03-18","current":-10.663883,"twenty":-21.326675,"median":-14.069914,"eighty":-8.83563,"marketCap":4841669529},{"date":"2022-03-25","current":-10.524816,"twenty":-21.159681,"median":-13.968769,"eighty":-8.83563,"marketCap":4778529385},{"date":"2022-04-01","current":-11.823798,"twenty":-21.003206,"median":-13.863231,"eighty":-8.83563,"marketCap":5368299964},{"date":"2022-04-08","current":-12.514551,"twenty":-20.910296,"median":-13.803148,"eighty":-8.83563,"marketCap":5681919142},{"date":"2022-04-14","current":-13.050955,"twenty":-20.848103,"median":-13.773354,"eighty":-8.83563,"marketCap":5925459699},{"date":"2022-04-22","current":-11.470781,"twenty":-20.717776,"median":-13.670793,"eighty":-8.83563,"marketCap":5208021136},{"date":"2022-04-29","current":-10.878745,"twenty":-20.624785,"median":-13.564241,"eighty":-8.83563,"marketCap":4939222202},{"date":"2022-05-06","current":-8.557526,"twenty":-20.519008,"median":-13.487652,"eighty":-8.833003,"marketCap":4023783190},{"date":"2022-05-13","current":-7.654777,"twenty":-20.519008,"median":-13.402239,"eighty":-8.786823,"marketCap":3599306930},{"date":"2022-05-20","current":-7.220506,"twenty":-20.519008,"median":-13.35812,"eighty":-8.748709,"marketCap":3395110773},{"date":"2022-05-27","current":-7.233891,"twenty":-20.519008,"median":-13.323757,"eighty":-8.718034,"marketCap":3401404490},{"date":"2022-06-03","current":-7.645854,"twenty":-20.519008,"median":-13.277877,"eighty":-8.684283,"marketCap":3595111119},{"date":"2022-06-10","current":-7.418308,"twenty":-20.519008,"median":-13.17025,"eighty":-8.65258,"marketCap":3488117927},{"date":"2022-06-17","current":-7.925453,"twenty":-20.519008,"median":-13.057111,"eighty":-8.633594,"marketCap":3726579878},{"date":"2022-06-24","current":-9.008157,"twenty":-20.52732,"median":-13.025475,"eighty":-8.615488,"marketCap":4235671668},{"date":"2022-07-01","current":-9.317501,"twenty":-20.52732,"median":-12.971944,"eighty":-8.615488,"marketCap":4381126466},{"date":"2022-07-08","current":-9.836545,"twenty":-20.52732,"median":-12.903988,"eighty":-8.615488,"marketCap":4625182832},{"date":"2022-07-15","current":-9.62982,"twenty":-20.52732,"median":-12.867014,"eighty":-8.615488,"marketCap":4527979867},{"date":"2022-07-22","current":-7.657752,"twenty":-20.52732,"median":-12.683542,"eighty":-8.593044,"marketCap":3600705534},{"date":"2022-07-29","current":-7.375537,"twenty":-20.52732,"median":-12.576503,"eighty":-8.565198,"marketCap":3731564327},{"date":"2022-08-05","current":-7.696694,"twenty":-20.52732,"median":-12.447093,"eighty":-8.50432,"marketCap":3894049860},{"date":"2022-08-12","current":-7.138822,"twenty":-20.52732,"median":-12.354843,"eighty":-8.455092,"marketCap":3611801282},{"date":"2022-08-19","current":-6.78721,"twenty":-20.52732,"median":-12.331685,"eighty":-8.434672,"marketCap":3433907638},{"date":"2022-08-26","current":-6.852272,"twenty":-20.52732,"median":-12.331685,"eighty":-8.389678,"marketCap":3466824966},{"date":"2022-09-02","current":-6.61002,"twenty":-20.52732,"median":-12.331685,"eighty":-8.359036,"marketCap":3344260447},{"date":"2022-09-09","current":-6.816281,"twenty":-20.52732,"median":-12.331685,"eighty":-8.331801,"marketCap":3448615380},{"date":"2022-09-16","current":-6.371921,"twenty":-20.52732,"median":-12.331685,"eighty":-8.289414,"marketCap":3223797034},{"date":"2022-09-23","current":-5.744834,"twenty":-20.52732,"median":-12.331685,"eighty":-8.245615,"marketCap":2906530022},{"date":"2022-09-30","current":-5.732376,"twenty":-20.52732,"median":-12.331685,"eighty":-8.208124,"marketCap":2900226703},{"date":"2022-10-07","current":-5.25064,"twenty":-20.52732,"median":-12.331685,"eighty":-8.150659,"marketCap":2656498403},{"date":"2022-10-14","current":-5.130206,"twenty":-20.52732,"median":-12.331685,"eighty":-8.077486,"marketCap":2595566328},{"date":"2022-10-21","current":-5.328161,"twenty":-20.52732,"median":-12.331685,"eighty":-8.010065,"marketCap":2695719049},{"date":"2022-10-28","current":-5.642396,"twenty":-20.52732,"median":-12.331685,"eighty":-7.967887,"marketCap":2854702739},{"date":"2022-11-04","current":-3.646694,"twenty":-20.52732,"median":-12.331685,"eighty":-7.881082,"marketCap":2472626416},{"date":"2022-11-11","current":-3.779038,"twenty":-20.52732,"median":-12.331685,"eighty":-7.854126,"marketCap":2562361653},{"date":"2022-11-18","current":-3.721138,"twenty":-20.52732,"median":-12.331685,"eighty":-7.7969,"marketCap":2523102487},{"date":"2022-11-25","current":-3.693221,"twenty":-20.52732,"median":-12.331685,"eighty":-7.738619,"marketCap":2504173960},{"date":"2022-12-02","current":-4.153323,"twenty":-20.52732,"median":-12.331685,"eighty":-7.69117,"marketCap":2816144121},{"date":"2022-12-09","current":-4.202952,"twenty":-20.52732,"median":-12.331685,"eighty":-7.649461,"marketCap":2849794835},{"date":"2022-12-16","current":-4.717852,"twenty":-20.52732,"median":-12.331685,"eighty":-7.588745,"marketCap":3198920992},{"date":"2022-12-23","current":-4.499692,"twenty":-20.52732,"median":-12.331685,"eighty":-7.55634,"marketCap":3050998062},{"date":"2022-12-30","current":-4.790228,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3247994949},{"date":"2023-01-06","current":-4.824348,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3271129815},{"date":"2023-01-13","current":-4.502794,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3053101231},{"date":"2023-01-20","current":-4.383891,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":2972479729},{"date":"2023-01-27","current":-4.520371,"twenty":-20.52732,"median":-12.331685,"eighty":-7.419224,"marketCap":3065019192},{"date":"2023-02-03","current":-4.728192,"twenty":-20.52732,"median":-12.331685,"eighty":-7.265696,"marketCap":3205931557},{"date":"2023-02-10","current":-4.549321,"twenty":-20.52732,"median":-12.331685,"eighty":-7.228067,"marketCap":3084648776},{"date":"2023-02-17","current":-4.834822,"twenty":-20.52732,"median":-12.331685,"eighty":-7.193971,"marketCap":3420254921},{"date":"2023-02-24","current":-4.342506,"twenty":-20.52732,"median":-12.331685,"eighty":-7.118611,"marketCap":3071980143},{"date":"2023-03-03","current":-4.536058,"twenty":-20.52732,"median":-12.331685,"eighty":-7.091607,"marketCap":3208902687},{"date":"2023-03-10","current":-3.847212,"twenty":-20.52732,"median":-12.331685,"eighty":-7.007538,"marketCap":2721598865},{"date":"2023-03-17","current":-3.824383,"twenty":-20.52732,"median":-12.331685,"eighty":-6.964752,"marketCap":2705449027},{"date":"2023-03-24","current":-3.740015,"twenty":-20.52732,"median":-12.331685,"eighty":-6.882782,"marketCap":2645764841},{"date":"2023-03-31","current":-3.980217,"twenty":-20.519008,"median":-12.327325,"eighty":-6.84769,"marketCap":2815689228},{"date":"2023-04-06","current":-3.845227,"twenty":-20.519008,"median":-12.327325,"eighty":-6.817229,"marketCap":2720194531},{"date":"2023-04-14","current":-3.834309,"twenty":-20.52732,"median":-12.331685,"eighty":-6.790561,"marketCap":2712470696},{"date":"2023-04-21","current":-4.095356,"twenty":-20.52732,"median":-12.331685,"eighty":-6.741883,"marketCap":2897140588},{"date":"2023-04-28","current":-4.242476,"twenty":-20.52732,"median":-12.331685,"eighty":-6.708105,"marketCap":3001216442},{"date":"2023-05-05","current":-4.503028,"twenty":-20.52732,"median":-12.331685,"eighty":-6.653176,"marketCap":3238005775},{"date":"2023-05-12","current":-4.638891,"twenty":-20.543943,"median":-12.127091,"eighty":-6.641982,"marketCap":3335701281},{"date":"2023-05-19","current":-5.014059,"twenty":-20.543943,"median":-12.030107,"eighty":-6.608226,"marketCap":3605474618},{"date":"2023-05-26","current":-4.91559,"twenty":-20.543943,"median":-11.942999,"eighty":-6.574925,"marketCap":3534667968},{"date":"2023-06-02","current":-4.885064,"twenty":-20.543943,"median":-11.851539,"eighty":-6.547631,"marketCap":3512717906},{"date":"2023-06-09","current":-5.079049,"twenty":-20.543943,"median":-11.661746,"eighty":-6.51973,"marketCap":3652207007},{"date":"2023-06-16","current":-4.811212,"twenty":-20.543943,"median":-11.483123,"eighty":-6.479975,"marketCap":3459612919},{"date":"2023-06-21","current":-4.936268,"twenty":-20.510696,"median":-11.421308,"eighty":-6.417082,"marketCap":3549537364},{"date":"2023-06-30","current":-4.593595,"twenty":-20.487227,"median":-11.238841,"eighty":-6.371161,"marketCap":3303130222},{"date":"2023-07-07","current":-4.482325,"twenty":-20.498962,"median":-11.187498,"eighty":-6.365701,"marketCap":3223118708},{"date":"2023-07-21","current":-4.237136,"twenty":-19.951513,"median":-11.097535,"eighty":-6.330057,"marketCap":3046810149},{"date":"2023-07-28","current":-4.134728,"twenty":-19.945557,"median":-11.07773,"eighty":-6.267685,"marketCap":2973171233},{"date":"2023-08-04","current":-4.057384,"twenty":-19.897508,"median":-11.023587,"eighty":-6.244893,"marketCap":2924314645},{"date":"2023-08-11","current":-3.621915,"twenty":-19.755822,"median":-10.996766,"eighty":-6.219342,"marketCap":2610455224},{"date":"2023-08-18","current":-3.463233,"twenty":-19.719512,"median":-10.937719,"eighty":-6.110593,"marketCap":2496086977},{"date":"2023-08-25","current":-3.666544,"twenty":-19.634346,"median":-10.899761,"eighty":-5.986933,"marketCap":2642621293},{"date":"2023-09-01","current":-3.648692,"twenty":-19.538575,"median":-10.863505,"eighty":-5.82457,"marketCap":2629754865},{"date":"2023-09-08","current":-4.080109,"twenty":-19.362208,"median":-10.802755,"eighty":-5.750563,"marketCap":2940693535},{"date":"2023-09-15","current":-3.893658,"twenty":-19.077218,"median":-10.732491,"eighty":-5.672427,"marketCap":2806310846},{"date":"2023-09-22","current":-3.630841,"twenty":-18.981061,"median":-10.679378,"eighty":-5.619716,"marketCap":2616888437},{"date":"2023-09-29","current":-3.488027,"twenty":-18.845186,"median":-10.612101,"eighty":-5.581034,"marketCap":2513957016},{"date":"2023-10-06","current":-3.468192,"twenty":-18.69861,"median":-10.535971,"eighty":-5.490331,"marketCap":2499660985},{"date":"2023-10-13","current":-3.237111,"twenty":-18.632497,"median":-10.521807,"eighty":-5.460417,"marketCap":2333112226},{"date":"2023-10-20","current":-3.7042,"twenty":-18.632497,"median":-10.443907,"eighty":-5.405085,"marketCap":2669761173},{"date":"2023-10-27","current":-3.893405,"twenty":-18.654427,"median":-10.382839,"eighty":-5.365218,"marketCap":2806128470},{"date":"2023-11-03","current":-4.68465,"twenty":-18.654427,"median":-10.364295,"eighty":-5.28414,"marketCap":2976073660},{"date":"2023-11-10","current":-4.517051,"twenty":-18.654427,"median":-10.342873,"eighty":-5.170628,"marketCap":2869601414},{"date":"2023-11-17","current":-5.034024,"twenty":-18.654427,"median":-10.305516,"eighty":-5.093229,"marketCap":3198025038},{"date":"2023-11-24","current":-5.058581,"twenty":-18.654427,"median":-10.281065,"eighty":-5.066839,"marketCap":3213625160},{"date":"2023-12-01","current":-5.0211,"twenty":-18.654427,"median":-10.19999,"eighty":-5.05703,"marketCap":3189814448},{"date":"2023-12-08","current":-5.353255,"twenty":-18.644324,"median":-10.171258,"eighty":-5.057805,"marketCap":3400826626},{"date":"2023-12-15","current":-5.933557,"twenty":-18.644324,"median":-10.119914,"eighty":-5.057805,"marketCap":3769482144},{"date":"2023-12-22","current":-5.885737,"twenty":-18.644324,"median":-10.02608,"eighty":-5.057805,"marketCap":3739102959},{"date":"2023-12-29","current":-6.238571,"twenty":-18.654427,"median":-9.99662,"eighty":-5.05703,"marketCap":3963252082},{"date":"2024-01-05","current":-6.086064,"twenty":-18.664531,"median":-9.939328,"eighty":-5.056254,"marketCap":3866367113},{"date":"2024-01-12","current":-5.964576,"twenty":-18.664531,"median":-9.900378,"eighty":-5.056254,"marketCap":3789187561},{"date":"2024-01-19","current":-5.578138,"twenty":-18.674634,"median":-9.811733,"eighty":-5.055479,"marketCap":3543690902},{"date":"2024-01-26","current":-5.848257,"twenty":-18.664531,"median":-9.7849,"eighty":-5.056254,"marketCap":3715292246},{"date":"2024-02-02","current":-5.699627,"twenty":-18.664531,"median":-9.642907,"eighty":-5.056254,"marketCap":3620870454},{"date":"2024-02-09","current":-5.874105,"twenty":-18.664531,"median":-9.594133,"eighty":-5.056254,"marketCap":3731713427},{"date":"2024-02-16","current":-6.261086,"twenty":-18.664531,"median":-9.561842,"eighty":-5.056254,"marketCap":3798219211},{"date":"2024-02-23","current":-6.634206,"twenty":-18.664531,"median":-9.488533,"eighty":-5.056254,"marketCap":4024568380},{"date":"2024-03-01","current":-7.019664,"twenty":-18.654427,"median":-9.448218,"eighty":-5.05703,"marketCap":4258401731},{"date":"2024-03-08","current":-6.901583,"twenty":-18.618504,"median":-9.331505,"eighty":-5.05703,"marketCap":4186769683},{"date":"2024-03-15","current":-6.331541,"twenty":-18.555722,"median":-9.248631,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-22","current":-6.331541,"twenty":-18.362305,"median":-9.119934,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-28","current":-6.354614,"twenty":-18.110177,"median":-9.054151,"eighty":-5.05703,"marketCap":3854956865},{"date":"2024-04-05","current":-6.389903,"twenty":-17.885675,"median":-8.975116,"eighty":-5.056254,"marketCap":3876364143},{"date":"2024-04-12","current":-6.881225,"twenty":-17.643907,"median":-8.928874,"eighty":-5.056254,"marketCap":4174419330},{"date":"2024-04-19","current":-5.887723,"twenty":-17.405641,"median":-8.865305,"eighty":-5.056254,"marketCap":3571722102},{"date":"2024-04-26","current":-5.951513,"twenty":-17.24545,"median":-8.784804,"eighty":-5.05703,"marketCap":3610419874},{"date":"2024-05-03","current":-5.85531,"twenty":-17.111877,"median":-8.730843,"eighty":-5.05703,"marketCap":3591360331},{"date":"2024-05-10","current":-5.582669,"twenty":-17.109146,"median":-8.602772,"eighty":-5.05703,"marketCap":3424135754},{"date":"2024-05-17","current":-5.770925,"twenty":-17.109146,"median":-8.502293,"eighty":-5.05703,"marketCap":3539602729},{"date":"2024-05-24","current":-5.403894,"twenty":-17.109146,"median":-8.437742,"eighty":-5.05703,"marketCap":3314483663},{"date":"2024-05-31","current":-5.234599,"twenty":-17.109146,"median":-8.326018,"eighty":-5.05703,"marketCap":3210646455},{"date":"2024-06-07","current":-5.657159,"twenty":-17.109146,"median":-8.22856,"eighty":-5.05703,"marketCap":3469824125},{"date":"2024-06-14","current":-6.362758,"twenty":-17.109548,"median":-8.139615,"eighty":-5.056254,"marketCap":3902604231},{"date":"2024-06-21","current":-5.610206,"twenty":-17.10995,"median":-8.062414,"eighty":-5.055479,"marketCap":3441025345},{"date":"2024-06-28","current":-6.111908,"twenty":-17.111877,"median":-7.980946,"eighty":-5.053152,"marketCap":3748744602},{"date":"2024-07-05","current":-5.933361,"twenty":-17.111877,"median":-7.91653,"eighty":-5.053152,"marketCap":3639232749},{"date":"2024-07-12","current":-6.476379,"twenty":-17.111877,"median":-7.842615,"eighty":-5.053152,"marketCap":3972293592},{"date":"2024-07-15","current":-6.660828,"twenty":-17.111877,"median":-7.815809,"eighty":-5.053152,"marketCap":4085425672},{"date":"2024-08-02","current":-6.829058,"twenty":-17.121885,"median":-7.700275,"eighty":-5.034024,"marketCap":3995825065},{"date":"2024-08-09","current":-7.915825,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4631715386},{"date":"2024-08-16","current":-8.142486,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4764339569},{"date":"2024-08-23","current":-8.871265,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5190763157},{"date":"2024-08-30","current":-8.965707,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5246023233},{"date":"2024-09-06","current":-8.885431,"twenty":-17.121885,"median":-7.70624,"eighty":-5.034024,"marketCap":5199052169},{"date":"2024-09-13","current":-9.102648,"twenty":-17.121885,"median":-7.774964,"eighty":-5.034024,"marketCap":5326150344},{"date":"2024-09-20","current":-9.252181,"twenty":-17.121885,"median":-7.849896,"eighty":-5.034024,"marketCap":5413645465},{"date":"2024-09-27","current":-8.691824,"twenty":-17.121885,"median":-7.916177,"eighty":-5.034024,"marketCap":5085769012},{"date":"2024-10-04","current":-8.446275,"twenty":-17.121885,"median":-7.994412,"eighty":-5.034024,"marketCap":4942092814},{"date":"2024-10-11","current":-8.47933,"twenty":-17.121885,"median":-8.063851,"eighty":-5.034024,"marketCap":4961433841},{"date":"2024-10-18","current":-8.9358,"twenty":-17.121885,"median":-8.144847,"eighty":-5.034024,"marketCap":5228524209},{"date":"2024-10-25","current":-8.628863,"twenty":-17.121885,"median":-8.21254,"eighty":-5.034024,"marketCap":5048928962},{"date":"2024-10-31","current":-8.1598,"twenty":-17.121885,"median":-8.258605,"eighty":-5.034024,"marketCap":4774470583},{"date":"2024-11-08","current":-8.324768,"twenty":-17.142899,"median":-8.319439,"eighty":-5.03169,"marketCap":4653445648},{"date":"2024-11-15","current":-7.864207,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395997435},{"date":"2024-11-22","current":-7.596785,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4246511376},{"date":"2024-11-29","current":-7.862556,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395074682},{"date":"2024-12-06","current":-7.814684,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4368314832},{"date":"2024-12-13","current":-7.7404,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4326790927},{"date":"2024-12-20","current":-7.175841,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4011209247},{"date":"2024-12-27","current":-7.233618,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4043505617},{"date":"2025-01-03","current":-6.792866,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":3797130446},{"date":"2025-01-10","current":-7.205555,"twenty":-17.163913,"median":-8.328682,"eighty":-5.029355,"marketCap":4027818809},{"date":"2025-01-17","current":-6.743343,"twenty":-17.163913,"median":-8.303187,"eighty":-5.029355,"marketCap":3769447843},{"date":"2025-01-24","current":-7.403646,"twenty":-17.163913,"median":-8.22856,"eighty":-5.029355,"marketCap":4138549223},{"date":"2025-01-31","current":-7.164286,"twenty":-17.163913,"median":-8.210902,"eighty":-5.029355,"marketCap":4004749973},{"date":"2025-02-07","current":-7.557166,"twenty":-17.163913,"median":-8.156652,"eighty":-5.029355,"marketCap":4224365294},{"date":"2025-02-14","current":-7.055416,"twenty":-17.163913,"median":-8.140574,"eighty":-5.029355,"marketCap":4015823014},{"date":"2025-02-21","current":-7.228695,"twenty":-17.163913,"median":-8.07435,"eighty":-5.029355,"marketCap":4114450084},{"date":"2025-02-28","current":-6.82078,"twenty":-17.163913,"median":-8.063851,"eighty":-5.029355,"marketCap":3882272258},{"date":"2025-03-07","current":-6.503875,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3701895062},{"date":"2025-03-14","current":-6.378738,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3630669195},{"date":"2025-03-21","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-03-28","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-04-04","current":-5.709174,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3249564556},{"date":"2025-04-11","current":-5.389018,"twenty":-17.163913,"median":-8.038932,"eighty":-5.047263,"marketCap":3067337338},{"date":"2025-04-17","current":-5.770746,"twenty":-17.163913,"median":-7.988725,"eighty":-5.047263,"marketCap":3284610351},{"date":"2025-04-25","current":-6.209573,"twenty":-17.184926,"median":-7.897222,"eighty":-5.047026,"marketCap":3534383465},{"date":"2025-05-02","current":-6.428987,"twenty":-17.184926,"median":-7.862556,"eighty":-5.047026,"marketCap":3659270022},{"date":"2025-05-09","current":-6.178877,"twenty":-17.184926,"median":-7.798177,"eighty":-5.047026,"marketCap":3395781282},{"date":"2025-05-16","current":-5.983104,"twenty":-17.184926,"median":-7.720227,"eighty":-5.047026,"marketCap":3288188434},{"date":"2025-05-23","current":-6.098164,"twenty":-17.184926,"median":-7.659513,"eighty":-5.047026,"marketCap":3351422827},{"date":"2025-05-30","current":-6.015733,"twenty":-17.184926,"median":-7.598263,"eighty":-5.047026,"marketCap":3306120575},{"date":"2025-06-06","current":-6.338587,"twenty":-17.184926,"median":-7.557166,"eighty":-5.047026,"marketCap":3483554394},{"date":"2025-06-13","current":-6.747307,"twenty":-17.184926,"median":-7.489485,"eighty":-5.047026,"marketCap":3708178059},{"date":"2025-06-20","current":-6.414149,"twenty":-17.20594,"median":-7.434667,"eighty":-5.04679,"marketCap":3525081458},{"date":"2025-06-27","current":-6.374651,"twenty":-17.20594,"median":-7.397868,"eighty":-5.04679,"marketCap":3503374129},{"date":"2025-07-03","current":-6.85378,"twenty":-17.20594,"median":-7.331032,"eighty":-5.04679,"marketCap":3766693467},{"date":"2025-07-11","current":-5.329668,"twenty":-17.20594,"median":-7.284263,"eighty":-5.04679,"marketCap":2929073710},{"date":"2025-07-18","current":-4.707144,"twenty":-17.20594,"median":-7.231156,"eighty":-5.019717,"marketCap":2586947330},{"date":"2025-07-25","current":-4.688253,"twenty":-17.20594,"median":-7.2205,"eighty":-4.990742,"marketCap":2576565564},{"date":"2025-08-01","current":-4.691688,"twenty":-17.20594,"median":-7.178045,"eighty":-4.933118,"marketCap":2578453158},{"date":"2025-08-08","current":-5.023544,"twenty":-17.20594,"median":-7.165937,"eighty":-4.922401,"marketCap":2677207288},{"date":"2025-08-15","current":-5.236544,"twenty":-17.120341,"median":-7.127226,"eighty":-4.922401,"marketCap":2790721647},{"date":"2025-08-22","current":-5.328603,"twenty":-16.992353,"median":-7.100943,"eighty":-4.922401,"marketCap":2839782937},{"date":"2025-08-29","current":-5.469399,"twenty":-16.931942,"median":-7.088351,"eighty":-4.922401,"marketCap":2914817852},{"date":"2025-09-05","current":-5.646297,"twenty":-16.867084,"median":-7.050962,"eighty":-4.921583,"marketCap":3009092489},{"date":"2025-09-12","current":-5.637272,"twenty":-16.862117,"median":-7.009732,"eighty":-4.922401,"marketCap":3004282559},{"date":"2025-09-19","current":-5.254594,"twenty":-16.862117,"median":-6.97646,"eighty":-4.922401,"marketCap":2800341507},{"date":"2025-09-26","current":-5.021739,"twenty":-16.862117,"median":-6.933137,"eighty":-4.922401,"marketCap":2676245302},{"date":"2025-10-03","current":-5.577704,"twenty":-16.789633,"median":-6.862153,"eighty":-4.922401,"marketCap":2972537018},{"date":"2025-10-10","current":-5.71489,"twenty":-16.494533,"median":-6.851457,"eighty":-4.922401,"marketCap":3045647960},{"date":"2025-10-17","current":-6.131864,"twenty":-16.395701,"median":-6.820464,"eighty":-4.922401,"marketCap":3267866747},{"date":"2025-10-24","current":-6.070492,"twenty":-16.196687,"median":-6.815304,"eighty":-4.922401,"marketCap":3235159220},{"date":"2025-10-31","current":-6.348474,"twenty":-16.144099,"median":-6.798969,"eighty":-4.922401,"marketCap":3383305078},{"date":"2025-11-07","current":-5.140525,"twenty":-15.97004,"median":-6.764352,"eighty":-4.922401,"marketCap":2980625358},{"date":"2025-11-14","current":-5.464403,"twenty":-15.83132,"median":-6.73876,"eighty":-4.922401,"marketCap":3168419201},{"date":"2025-11-21","current":-5.178726,"twenty":-15.666995,"median":-6.672392,"eighty":-4.922401,"marketCap":3002775401},{"date":"2025-11-28","current":-5.771672,"twenty":-15.537051,"median":-6.632421,"eighty":-4.922401,"marketCap":3346582591},{"date":"2025-12-05","current":-6.068975,"twenty":-15.441819,"median":-6.604679,"eighty":-4.922401,"marketCap":3518967708},{"date":"2025-12-12","current":-6.012504,"twenty":-15.299877,"median":-6.546356,"eighty":-4.922401,"marketCap":3486224167},{"date":"2025-12-19","current":-5.454437,"twenty":-15.157139,"median":-6.505037,"eighty":-4.922401,"marketCap":3162640929},{"date":"2025-12-26","current":-5.743436,"twenty":-15.063399,"median":-6.472501,"eighty":-4.922401,"marketCap":3330210820},{"date":"2026-01-02","current":-3.820099,"twenty":-14.92224,"median":-6.441626,"eighty":-4.914015,"marketCap":2215004305},{"date":"2026-01-09","current":-3.854978,"twenty":-14.820259,"median":-6.429125,"eighty":-4.885543,"marketCap":2235228257},{"date":"2026-01-16","current":-3.903145,"twenty":-14.402748,"median":-6.402171,"eighty":-4.843904,"marketCap":2263156572},{"date":"2026-01-23","current":-3.886536,"twenty":-13.999808,"median":-6.386141,"eighty":-4.813839,"marketCap":2253526119},{"date":"2026-01-30","current":-4.031035,"twenty":-13.404405,"median":-6.378891,"eighty":-4.770249,"marketCap":2337311064},{"date":"2026-02-06","current":-3.951311,"twenty":-13.236481,"median":-6.373339,"eighty":-4.730852,"marketCap":2291084887}],"updateTime":1770514520657},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RARE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609581257","title":"Ultragenyx Pharmaceutical Inc. to Host Conference Call for Financial Results and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2609581257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609581257?lang=en_us&edition=fundamental","pubTime":"2026-02-06 05:06","pubTimestamp":1770325561,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire  on February 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL86kTRX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4588","BK4112","IE00B3QW5Z07.USD","BK4139","LU0314104364.USD","LU2095319765.USD","NDAQ","SG9999014039.USD","SG9999014021.USD","LU2210149790.SGD","RARE","SG9999014013.SGD","BK4585","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2609931034","title":"Ultragenyx Faces Investor Lawsuit Over Alleged Misleading Statements on Drug Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2609931034","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609931034?lang=en_us&edition=fundamental","pubTime":"2026-02-05 08:44","pubTimestamp":1770252275,"startTime":"0","endTime":"0","summary":"A class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc., representing investors who purchased or acquired the company’s common stock between August 3, 2023, and December 26, 2025. The lawsuit alleges that Ultragenyx and certain executives violated the Securities Exchange Act of 1934 by making false or misleading statements regarding the effects of setrusumab on patients with various types of Osteogenesis Imperfecta during its Phase III Orbit study. Specifically, the complaint claims the company created a misleading impression of the reliability of its data and downplayed risks related to the study’s design, particularly the lack of a placebo control group in earlier trials. Investors who suffered substantial losses during the stated period may seek appointment as lead plaintiff in the case.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-g","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDLbqNp0R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","SG9999014005.SGD","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4139","LU2210150020.SGD","SG9999014013.SGD","BK4585","BK4588","LU2210149790.SGD","NDAQ","RARE","SG9999014039.USD","BK4112"],"gpt_icon":0},{"id":"2608354343","title":"Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608354343","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608354343?lang=en_us&edition=fundamental","pubTime":"2026-02-04 10:51","pubTimestamp":1770173469,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ultragenyx Pharmaceutical (RARE – Research Report) and Pfizer (PF...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ultragenyx-pharmaceutical-rare-and-pfizer-pfe-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ultragenyx-pharmaceutical-rare-and-pfizer-pfe-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0225284248.USD","LU0170899867.USD","BK4533","BK4585","SG9999001176.USD","BK4534","LU0029874061.USD","LU0321505439.SGD","BK4007","SG9999003800.SGD","LU0306807586.USD","BK4139","BK4137","LU1057294990.SGD","LU1066051498.USD","LU0128526141.USD","LU0985481810.HKD","IE00BBT3K403.USD","BK4568","BK4550","LU1894683264.USD","RARE","SG9999002224.SGD","SG9999002232.USD","IE00B19Z3581.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0868494617.USD","SG9999001176.SGD","LABU","LU0122379950.USD","XBI","IE00B19Z3B42.SGD","LU0289739699.SGD","SGXZ57979304.SGD","BK4581","LU0321505868.SGD","LU0234572021.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU0058720904.USD","BK4588","LU0225771236.USD","IE0002270589.USD","LU1066053197.SGD","LU1883839398.USD","LU1894683348.USD","SG9999013999.USD","PFE","LU0456855351.SGD","SG9999011175.SGD","BK4599","LU1023059063.AUD","BK4592"],"gpt_icon":0},{"id":"2608480971","title":"Ultragenyx Says Gene Therapy Shows Lasting Benefits, Slows Brain Decline In Fatal Childhood Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2608480971","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608480971?lang=en_us&edition=fundamental","pubTime":"2026-02-04 01:58","pubTimestamp":1770141480,"startTime":"0","endTime":"0","summary":"Ultragenyx reported long-term study data showing lasting brain and skill improvements with UX111 for Sanfilippo syndrome, supporting its resubmitted FDA application ahead of a 2026 decision.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/03/Gene-therapy.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/03/Gene-therapy.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/02/50345196/ultragenyx-says-gene-therapy-shows-lasting-benefits-slows-brain-decline-in-fatal-childhood-disorder","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/02/50345196/ultragenyx-says-gene-therapy-shows-lasting-benefits-slows-brain-decline-in-fatal-childhood-disorder","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2608063628","title":"Ultragenyx CFO Howard Horn Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2608063628","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608063628?lang=en_us&edition=fundamental","pubTime":"2026-02-04 01:01","pubTimestamp":1770138078,"startTime":"0","endTime":"0","summary":"Howard Horn, Chief Financial Officer of Ultragenyx Pharmaceutical Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL26zvbl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ultragenyx CFO Howard Horn Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2608787246","title":"BUZZ-U.S. STOCKS ON THE MOVE-JetBlue, VSE, Walt Disney","url":"https://stock-news.laohu8.com/highlight/detail?id=2608787246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608787246?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:17","pubTimestamp":1770128229,"startTime":"0","endTime":"0","summary":"** Palantir Technologies Inc PLTR.O:BUZZ - Jumps as US government contracts boost quarterly sales nL4N3YZ0PE** Merck & Co Inc MRK.N:BUZZ - Falls on downbeat 2026 profit and sales forecasts nL4N3YZ0U8     ** Newmont Corp NEM.N:     ** Gold Fields Ltd GFI.N:** AngloGold Ashanti PLC AU.N: ** Harmony Gold Mining Co Ltd HMY.N:BUZZ - Gold, silver miners gain as metal prices edge higher after two-session rout nL4N3YZ0ST** McDonald's Corp MCD.N:BUZZ - Up after brokerage BTIG upgrades to 'buy'  nL6N3YY0WK** SoFi Technologies Inc SOFI.O:BUZZ - Rises after J.P. Morgan upgrades to 'overweight' nL6N3YZ0MY     ** Rio Tinto PLC RIO.N:              ** BHP Group Ltd BHP.N:** Southern Copper Corp SCCO.N: ** Freeport-McMoRan Inc FCX.N:BUZZ - Copper miners rise on China stockpiling, stronger risk sentiment nL4N3YZ0W3** PepsiCo Inc PEP.O:BUZZ - Falls after reaffirming annual earnings forecast despite Q4 revenue beat nL4N3YZ0YH** FedEx Corp FDX.N:BUZZ - Gains after Bernstein upgrades rating to 'outperform' ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nL6N3YZ0PY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","PLTW","MCD","HPQ","PLOO","DIS","PLTG","JBLU","DVA","PYPY","SOFX","VSEC","NEM","BALL","SCNX","PLTZ","PLTU","MPC","RIO.UK","AU","PLYY","RARE","RIO.AU","PEP","PLTY","PYPG","GTBP","LU1162221912.USD","PTIR","PLT","LU1066051225.USD","ADM","WST","SOC","BHP.AU","PLTD","EVR","FDX","BK4559","OVV","ETN","LU1223082196.USD","MRK","PLTA"],"gpt_icon":1},{"id":"2608701872","title":"Ultragenyx Says Long-Term Data Show UX111 Provides Clinical Benefits in Sanfilippo Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2608701872","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608701872?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:09","pubTimestamp":1770127757,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical  said Tuesday that its investigational gene therapy UX111 achieved \"substantial and durable\" biomarker improvements and provided \"meaningful\" functional benefits in patients with Sanfilippo syndrome type A, or MPS IIIA, through 8.5 years of follow-up.The company said the improvements compared with natural history were observed across age groups and disease severity, and UX111 continued to be well-tolerated with a favorable safety profile.Ultragenyx said it included these new data in its biologics license application for UX111, which it resubmitted to the US Food and Drug Administration in January.The company said it expects a review period of up to six months, with a target action date anticipated in Q3.Shares of Ultragenyx were up more than 1% in recent premarket activity Tuesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2608190871","title":"Ultragenyx Pharma Price Target Maintained With a $60.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2608190871","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608190871?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:26","pubTimestamp":1770125160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RARE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 03, 2026 08:26 ET (13:26 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2608879265","title":"BRIEF-Ultragenyx: Long-Term UX111 Data Shows Sustained CSF-HS Reductions, Multi-Domain Gains In Children With Sanfilippo Syndrome (Mps Iiia)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879265","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879265?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:09","pubTimestamp":1770124153,"startTime":"0","endTime":"0","summary":"BRIEF-Ultragenyx: Long-Term UX111 Data Shows Sustained CSF-HS Reductions, Multi-Domain Gains In Children With Sanfilippo Syndrome (Mps Iiia)Feb 3 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O:ULTRA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ130:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2608879387","title":"Ultragenyx Announces Positive Longer-Term Data Demonstrating Treatment With Ux111 Gene Therapy Results in Sustained, Significant Reductions in Csf-Hs and Continued Meaningful Improvements in Clinical Function Across Multiple Developmental Domains in Children With Sanfilippo Syndrome (Mps Iiia)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879387?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:01","pubTimestamp":1770123704,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ130:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2608581879","title":"Ultragenyx Pharmaceutical Inc - Results Show Substantial Biomarker Improvements and Functional Benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2608581879","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608581879?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:01","pubTimestamp":1770123704,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ130:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2608487958","title":"Ultragenyx Pharmaceutical Inc - Ux111 Well Tolerated Across All Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2608487958","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608487958?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:01","pubTimestamp":1770123704,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ130:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2608287938","title":"Ultragenyx Pharmaceutical Inc - Bla Resubmitted to FDA, Six-Month Review Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2608287938","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608287938?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:01","pubTimestamp":1770123704,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ130:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2608879340","title":"Ultragenyx Resubmits BLA for UX111 Gene Therapy to FDA with PDUFA Date Expected in Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879340","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879340?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:00","pubTimestamp":1770123636,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical Inc. has announced the resubmission of its Biologics License Application  to the U.S. Food and Drug Administration  for UX111 , an investigational gene therapy for Sanfilippo syndrome Type A . The company expects the FDA to review the application under an accelerated approval pathway, with a Prescription Drug User Fee Act  date anticipated in the third quarter of 2026. The review period is expected to last up to six months, in accordance with FDA guidelines.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire  on February 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL2cPYlS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE","BK4588","LU0314104364.USD","BK4112","BK4585","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014021.USD","SG9999014013.SGD","NDAQ","IE00BKPKM429.USD","LU2210150020.SGD","BK4139","SG9999014005.SGD","IE00BGHQF748.EUR","SG9999014039.USD"],"gpt_icon":0},{"id":"2608388415","title":"Ultragenyx BLA Resubmission Puts UX111 And RARE Valuation In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2608388415","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608388415?lang=en_us&edition=fundamental","pubTime":"2026-02-02 01:21","pubTimestamp":1769966469,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical resubmitted its Biologics License Application to the FDA for UX111, a gene therapy candidate for Sanfilippo syndrome type A.\nThe filing includes long term clinical data and responses to earlier regulatory concerns about the therapy.\nIf accepted, UX111 could become the first approved treatment specifically targeting this rare and serious condition.\n\nUltragenyx Pharmaceutical (NasdaqGS:RARE), trading at $24.07 as of the last close, is moving ahead with a key...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rare/ultragenyx-pharmaceutical/news/ultragenyx-bla-resubmission-puts-ux111-and-rare-valuation-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rare/ultragenyx-pharmaceutical/news/ultragenyx-bla-resubmission-puts-ux111-and-rare-valuation-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2607491700","title":"Ultragenyx Resubmits FDA Application for Potential Therapy for Rare Neurodegeneration Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2607491700","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607491700?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:11","pubTimestamp":1769782312,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical  said Friday it has resubmitted its biologics license application for accelerated approval of gene therapy UX111 to treat Sanfilippo syndrome type A to the US Food and Drug Administration.The resubmission follows a complete response letter issued by the FDA in July and includes longer-term data on treatment benefits to back up a clinical endpoint for accelerated approval, the company said.The updated data shows \"a durable treatment effect\" across multiple biomarkers and an \"acceptable\" safety profile, Ultragenyx said.The company said it anticipates up to a six-month review period.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2607046387","title":"Ultragenyx resubmits BLA for UX111 gene therapy with FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2607046387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607046387?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:40","pubTimestamp":1769780425,"startTime":"0","endTime":"0","summary":"Ultragenyx (RARE) Pharmaceutical announced that it has resubmitted its Biologics License Application, BLA, seeking accelerated approval for UX111 A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-resubmits-bla-for-ux111-gene-therapy-with-fda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-resubmits-bla-for-ux111-gene-therapy-with-fda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2607204545","title":"FDA Grants Priority Review to Ultragenyx BLA for UX111 Gene Therapy for Sanfilippo Syndrome Type A","url":"https://stock-news.laohu8.com/highlight/detail?id=2607204545","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607204545?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779830,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical Inc. has resubmitted its Biologics License Application  to the U.S. Food and Drug Administration  for UX111 , an AAV9 gene therapy intended to treat patients with Sanfilippo syndrome type A . The FDA granted Priority Review to the application in February 2025. A Prescription Drug User Fee Act  action date is expected to be assigned within a month of resubmission, with a review period of up to six months anticipated, and a PDUFA date projected for the third quarter of 2026. If approved, UX111 would become the first therapy available for Sanfilippo syndrome type A.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via Glo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL6P10gg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","LU2210150020.SGD","SG9999014021.USD","LU0314104364.USD","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","LU2095319765.USD","NDAQ","BK4139","SG9999014013.SGD","SG9999014039.USD","RARE","IE00B64PRP62.GBP","BK4112","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2607451900","title":"Ultragenyx Pharmaceutical Inc: Expects up to Six-Month Review Period per FDA Guidelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2607451900","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607451900?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA1RSB9J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2607451710","title":"Ultragenyx Pharmaceutical Inc - Bla Includes Responses to Cmc Observations From July 2025 Crl","url":"https://stock-news.laohu8.com/highlight/detail?id=2607451710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607451710?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA1RSB9J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RARE"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":135,"code":"91000000","status":"200"}]}}